ICICI Prudential Nifty Pharma Index Fund (Direct)
ICICI Prudential Mutual Fund · benchmark Nifty Pharma TRI · 3.9 years old · AMFI code 150930
B (middle of the peer group), score 50.0 out of 100. Describes the past, not a forecast.
Returns against the index
| Period | Fund | Index (TRI) | Difference | Rank in category |
|---|---|---|---|---|
| 6 months | 17.3% | 17.6% | -0.3% | 1 / 1 |
| 1 year | 23.7% | 24.3% | -0.6% | 1 / 1 |
| 3 years (a year) | 22.9% | 23.7% | -0.8% | 1 / 1 |
| 5 years (a year) | – | – | – | – |
Growth option, point to point to 5 Nov 2026; periods over a year are annualised (CAGR). Index returns use the total-return index, which includes dividends.
Risk
Portfolio
Top 10 holdings, September 2026 portfolio.
Similar funds
Common questions
What is the NAV of ICICI Prudential Nifty Pharma Index Fund (Direct plan)?
₹21.37 on 5 Nov 2026 (Growth option).
What is the expense ratio of ICICI Prudential Nifty Pharma Index Fund (Direct)?
0.51% a year; the Regular plan's is 1.13%.
What return has ICICI Prudential Nifty Pharma Index Fund given over 3 years?
22.9% a year (Direct plan) over the 3 years to 5 Nov 2026, against 23.7% for the Nifty Pharma total-return index.
What does ICICI Prudential Nifty Pharma Index Fund invest in?
Its largest holdings are Sun Pharmaceutical Industries Ltd., Divi's Laboratories Ltd., Laurus Labs Ltd., with 20 stocks in all (September 2026 portfolio).
How is ICICI Prudential Nifty Pharma Index Fund rated?
B: 1 of 1 Direct plans in Index: NIFTY PHARMA, on its track record. This describes the past and is not a recommendation.
Data as of 5 Nov 2026: NAVs from AMFI, index data from NSE Indices, portfolios from ICICI Prudential Mutual Fund's monthly disclosure. Updated every weekday. Read the scheme documents before investing.